Pharmaniaga Berhad,a PN17 company, appears to be on track with its regularisation plan. We speak with Managing Director Zulkifli Jaafar on the company’s restructuring efforts, how they plan to grow operations, and what this means for the future of one of Malaysia’s key pharmaceutical players which has a lucrative government concession agreement.

Pharmaniaga Berhad,a PN17 company, appears to be on track with its regularisation plan. We speak with Managing Director Zulkifli Jaafar on the company’s restructuring efforts, how they plan to grow operations, and what this means for the future of one of Malaysia’s key pharmaceutical players which has a lucrative government concession agreement.

Sharper and stronger than a double espresso. The Morning Run stretches your mind and braces you for the business day. It's your fast track into work where you can hit the ground running. From 6am to 10am weekdays, the Morning Run brings you the biggest stories and must-listen-to interviews. Stay enlightened, make educated business and investment decisions.

The Breakfast Grille

Featuring the cream-of-the-crop as well as the controversial, the Breakfast Grille is the flagship show of BFM. Expect no-holds-barred interviews to get to the truth and into the minds of business leaders, policymakers and changemakers.

Pharmaniaga Easing Its Way Out Of PN17

Pharmaniaga officially exited PN17 status in March, having taken three years to complete its regularisation plan. The firm is now vying to become the most valuable pharmaceutical company in Malaysia by 2030 leveraging on its ongoing government concession in logistics and biopharma manufacturing capabilities. We catch-up with Managing Director Dato’ Zulkifli Jafar to find out how he intends to achieve this goal.

Pharmaniaga officially exited PN17 status in March, having taken three years to complete its regularisation plan. The firm is now vying to become the most valuable pharmaceutical company in Malaysia by 2030 leveraging on its ongoing government concession in logistics and biopharma manufacturing capabilities. We catch-up with Managing Director Dato’ Zulkifli Jafar to find out how he intends to achieve this goal.

Pharmaniaga Post-PN17 Betting Big on Biopharma

Still fresh from his re-entry into UMNO, we ask the former Minister and Youth Chief what role he sees for himself in the party ahead of GE16, and his views on the Barisan-Pakatan cooperation and what the Malay community wants. We also tap him for his views on great power rivalry, the US-Israeli attack on Iran and the global crisis it has created. Are our political elite up to the task of navigating the global crisis, or will they keep our house permanently divided?

Still fresh from his re-entry into UMNO, we ask the former Minister and Youth Chief what role he sees for himself in the party ahead of GE16, and his views on the Barisan-Pakatan cooperation and what the Malay community wants. We also tap him for his views on great power rivalry, the US-Israeli attack on Iran and the global crisis it has created. Are our political elite up to the task of navigating the global crisis, or will they keep our house permanently divided?

Khairy Jamaluddin: Back in the Running

How is the US-China geopolitical rivalry affecting other countries also involved in the semiconductor space, like the Netherlands and Malaysia? We discuss the Dutch approach to semiconductor advancement and lessons that can be learned by Malaysia in growing its domestic industry with Michiel Sweers, Vice Minister for Foreign Economic Relations of the Netherlands.

How is the US-China geopolitical rivalry affecting other countries also involved in the semiconductor space, like the Netherlands and Malaysia? We discuss the Dutch approach to semiconductor advancement and lessons that can be learned by Malaysia in growing its domestic industry with&nbsp;Michiel Sweers, Vice Minister for Foreign Economic Relations of the Netherlands.

Pharmaniaga Easing Its Way Out Of PN17

In 1 playlist(s)

The Breakfast Grille

Social links

Follow podcast

Recent clips